• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Forbion Continues Funding Efforts, Raises $208M for More Investments

cafead

Administrator
Staff member
  • cafead   Jul 09, 2020 at 10:42: PM
via Forbion, a European life sciences venture capital firm, announced today that it had closed its Forbion Growth Opportunities Fund at $208 million. Existing investors including Pantheon, KfW Capital and the European Investment Fund contributed to the financing, which will go toward late-stage investments.

article source